Skip to content

De novo generation and computational screening of dual-targeting short peptide inhibitors against PBP2b and PBP2x in drug-resistant Streptococcus Pneumoniae.

Sep 2026 · Molecular diversity · 0 citations · 104 references
Medicine

TL;DR

Overall, SPB-Seeker provides an extensible computational framework for targeted short peptide binder discovery and offers a basis for subsequent affinity optimization and stability enhancement.

View source

Similar papers

Sep 2026

Efflux pump gene ABCA as targets for deep learning-based de novo inhibitors in invasive aspergillosis caused by Aspergillus fumigatus.

This study aims to design and evaluate novel therapeutic binders targeting the ATP-binding region of the AbcA efflux transporter protein in Aspergillus fumigatus. By inhibiting ATP binding, these binders seek to prevent AbcA-mediated azole resistance and restore the effectiveness of antifungal treatments. The research...

N. M. Ahmed, Rand Salwan Numan Ismail, A. Suleiman · 0 citations
Open access 2026

De Novo Design of Novel Pks13 Inhibitors Rational Drug Design via Machine Learning-Guided Molecular Docking and QSAR Modelling for Mycobacterial Mycolic Acid Biosynthesis Inhibition

Tuberculosis remains one of the world's most significant infectious diseases, with approximately 10 million new cases annually. The polyketide synthase 13 (Pks13) enzyme, responsible for the final cyclopropanation step of mycolic acid biosynthesis, has remained understudied as an antituberculous drug target despite its...

P. Muthenna, Anugula Chandra Shekhar · 0 citations
#graph neural networks Open access Aug 2026

Discovery of a potent TDP1 inhibitor through machine learning-driven predictive modeling combined with structure-based virtual screening and experimental validation

An integrated computational framework combining machine learning (ML), deep learning (DL), and structure-based docking with experimental validation identifies AO65 as a promising lead for further TDP1-focused investigation.

Huang Zeng, Man-Yi Zhang, Bo Qiu et al. · 0 citations
Aug 2026

Targeting WEE1 kinase: an integrated machine learning–cheminformatics framework for ultra-large-scale virtual screening and novel inhibitor discovery

A scalable, machine-learning-integrated virtual screening framework designed to explore ultra-large chemical space spanning an input search space of approximately 884 million compounds from ZINC20 and 199,854 purchasable compounds from the SPECS database is reported.

R. Muthuraj, Manasa Pacharla, Nehal Arvind Kumar et al. · 0 citations
Open access Aug 2026

Machine Learning‐Based Discovery of Natural PknB Inhibitors Against Drug‐Resistant Mycobacterium tuberculosis With Multi‐Scale Modeling and Quantum Mechanical Validation

An integrated computational workflow to identify natural small molecules with high potential to bind protein kinase B (PknB) identifies promising PknB inhibitors for further experimental validation and offers an efficient platform to accelerate natural‐product‐based anti‐TB drug discovery.

Rahul Singh, Vishwas Tripathi, Vivek Dhar Dwivedi et al. · 1 citation
Aug 2026

From In Silico De Novo Generation to In Vitro Functional Validation: Discovery of Multifunctional Antithrombotic Peptides from Food-Derived Proteins via a Hybrid LSTM-GCN and Molecular Simulation Pipeline.

Cardiovascular thromboses bring heavy global health burdens, while traditional screening of food-derived antithrombotic peptides is inefficient. This work built an integrated pipeline integrating de novo peptide generation, hybrid LSTM-GCN deep learning, and molecular simulations, screening 15,000 sequences to obtain l...

Hui-Zhen Xing, Hui-Min Dong, Cheng-Zhi Guo et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.